A nanoparticle platform for multiple immune tolerance therapies

Time: 3:00 pm
day: Day One


  • Broad therapeutic potential of our proprietary Topas Particle Conjugates delivering peptide antigens to special liver cells
  • Diverse mechanism-of-action through different immune pathways to rebalance the immune system
  • Pemphigus vulgaris and Celiac disease as strong clinical models